Literature DB >> 6573294

Massive blastic infiltration of the liver: a cause of fulminant hepatic failure.

E S Zafrani, B Leclercq, J P Vernant, Y Pinaudeau, G Chomette, D Dhumeaux.   

Abstract

The clinical and pathological findings in four cases of fulminant hepatic failure due to massive infiltration of the liver by acute leukemia or lymphoma are reported. Liver abnormalities were found simultaneously with or led to the discovery of hematologic malignancies, and consisted of marked hepatomegaly and severe hepatocellular insufficiency associated with hyperlactatemia. The blood malignancies were peculiar in their fast cellular growth and large tumor mass. Evolution was rapidly fatal in all these cases. In another patient, marked hepatomegaly and hyperlactatemia revealed the presence of a widespread lymphoma before the appearance of hepatocellular insufficiency. Immediate chemotherapy was instituted, and complete remission without hepatic complication was obtained. It is suggested that malignant hematological diseases with fast cellular growth may present as fulminant hepatic failure. In order to avoid a rapidly fatal outcome secondary to liver failure and metabolic disorders, early recognition of these malignancies is necessary so as to assure prompt administration of appropriate chemotherapy.

Entities:  

Mesh:

Year:  1983        PMID: 6573294     DOI: 10.1002/hep.1840030324

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

1.  Acute liver failure as an initial manifestation of an infiltrative hematolymphoid malignancy.

Authors:  Yasser M Bhat; Alyssa Krasinskas; Fiona E Craig; Thomas A Shaw-Stiffel
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

Review 2.  Fulminant Hepatic Failure Secondary to Metastatic Transitional Cell Carcinoma-Case Report and Review of the Literature.

Authors:  Aijaz Ahmed Sofi; Luis de Las Casas; Zeeshan Tariq; Ali Nawras; Wael Youssef
Journal:  J Gastrointest Cancer       Date:  2012-09

Review 3.  Acute liver failure due to natural killer-like T-cell leukemia/lymphoma: a case report and review of the literature.

Authors:  Evan S Dellon; Shannon R Morris; Wozhan Tang; Cherie H Dunphy; Mark W Russo
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

4.  Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases.

Authors:  D Rowbotham; J Wendon; R Williams
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

5.  A case of peripheral T-cell lymphoma presenting with acute liver failure.

Authors:  Naoki Konno; Atsushi Takahashi; Kenya Watanabe; Fumiko Katsushima; Kyoko Monoe; Yukiko Kanno; Hironobu Saito; Kazumichi Abe; Hiromasa Ohira
Journal:  Clin J Gastroenterol       Date:  2011-11-27

Review 6.  Acute liver failure due to hepatic involvement by hematologic malignancy.

Authors:  T M Shehab; M S Kaminski; A S Lok
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

Review 7.  Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation.

Authors:  G M Woolf; L M Petrovic; S E Rojter; F G Villamil; L Makowka; L G Podesta; L S Sher; L Memsic; J M Vierling
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

8.  Hepatic encephalopathy associated with cancer or anticancer therapy.

Authors:  Kaspar J Willson; Louise M Nott; Vy T Broadbridge; Timothy Price
Journal:  Gastrointest Cancer Res       Date:  2013-01

Review 9.  Angiosarcoma of the liver as a cause of fulminant liver failure.

Authors:  Marco Montell García; Raúl Romero Cabello; Raul Romero Feregrino; Mercado Atri Moises; Rafael Trejo Estrada; Padilla-Rodríguez Alvaro; Gama Moreno Manlio Gerardo; Romero Feregrino Rodrigo
Journal:  BMJ Case Rep       Date:  2012-08-02

10.  Acute Liver Failure due to Miliary Liver Metastasis.

Authors:  Charles A Lavender; Jessica Stout; Hui-Yong Chung; Michael Johnson; Ragesh B Thandassery
Journal:  ACG Case Rep J       Date:  2020-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.